From Specimen to Result: Streamlining Breast Cancer Biomarker Workflows in a Hybrid Academic-Community Health System

This webinar will explore the implementation of precision cancer biomarker testing pathways in a hybrid health system comprised of both private-community and academic practice settings. It will broadly cover the technology and administrative processes used to create these testing pathways, with a deeper focus specifically on the breast cancer disease state. Attendees will leave the webinar being able to examine implementation of a flexible NGS-oncology testing solution enabling disease-specific and comprehensive cancer diagnostics, identify key steps in the development of multi-disciplinary cancer biomarker testing pathways and evaluate the impact of in-system biomarker testing on quality of cancer patient care.

This webinar is the second in the four-part series, "Streamlining Precision Oncology Testing Protocols: Present Practices, Prospects and Problems." The series is supported by funding from Amgen and AstraZeneca.